{
  "id": "https://openalex.org/W2103134643",
  "doi": "https://doi.org/10.1200/jco.2004.06.075",
  "title": "Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck",
  "display_name": "Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck",
  "publication_year": 2003,
  "publication_date": "2003-12-30",
  "ids": {
    "openalex": "https://openalex.org/W2103134643",
    "doi": "https://doi.org/10.1200/jco.2004.06.075",
    "mag": "2103134643",
    "pmid": "https://pubmed.ncbi.nlm.nih.gov/14701768"
  },
  "language": "en",
  "primary_location": {
    "is_oa": true,
    "landing_page_url": "https://doi.org/10.1200/jco.2004.06.075",
    "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.06.075?role=tab",
    "source": {
      "id": "https://openalex.org/S15137598",
      "display_name": "Journal of Clinical Oncology",
      "issn_l": "0732-183X",
      "issn": [
        "0732-183X",
        "1527-7755"
      ],
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": true,
      "is_core": true,
      "host_organization": "https://openalex.org/P4310315671",
      "host_organization_name": "Lippincott Williams & Wilkins",
      "host_organization_lineage": [
        "https://openalex.org/P4310315671",
        "https://openalex.org/P4310318547"
      ],
      "host_organization_lineage_names": [
        "Lippincott Williams & Wilkins",
        "Wolters Kluwer"
      ],
      "type": "journal"
    },
    "license": null,
    "license_id": null,
    "version": "publishedVersion",
    "is_accepted": true,
    "is_published": true
  },
  "type": "article",
  "type_crossref": "journal-article",
  "indexed_in": [
    "crossref",
    "pubmed"
  ],
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.06.075?role=tab",
    "any_repository_has_fulltext": false
  },
  "authorships": [
    {
      "author_position": "first",
      "author": {
        "id": "https://openalex.org/A5064078958",
        "display_name": "Denis Souli√®res",
        "orcid": "https://orcid.org/0000-0002-1533-3815"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Denis Soulieres",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    },
    {
      "author_position": "middle",
      "author": {
        "id": "https://openalex.org/A5111839131",
        "display_name": "Neil Senzer",
        "orcid": null
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Neil N. Senzer",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    },
    {
      "author_position": "middle",
      "author": {
        "id": "https://openalex.org/A5063904421",
        "display_name": "Everett E. Vokes",
        "orcid": "https://orcid.org/0000-0002-8645-8068"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Everett E. Vokes",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    },
    {
      "author_position": "middle",
      "author": {
        "id": "https://openalex.org/A5086660695",
        "display_name": "Manuel Hidalgo",
        "orcid": "https://orcid.org/0000-0002-3765-3318"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Manuel Hidalgo",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    },
    {
      "author_position": "middle",
      "author": {
        "id": "https://openalex.org/A5061683749",
        "display_name": "Sanjiv S. Agarwala",
        "orcid": "https://orcid.org/0000-0001-9416-8768"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Sanjiv S. Agarwala",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    },
    {
      "author_position": "last",
      "author": {
        "id": "https://openalex.org/A5000204204",
        "display_name": "Lillian L. Siu",
        "orcid": "https://orcid.org/0000-0002-3500-0540"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I2802654988",
          "display_name": "Princess Margaret Cancer Centre",
          "ror": "https://ror.org/03zayce58",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441",
            "https://openalex.org/I2802654988"
          ]
        },
        {
          "id": "https://openalex.org/I4210156829",
          "display_name": "Research Network (United States)",
          "ror": "https://ror.org/04tgjxk96",
          "country_code": "US",
          "type": "company",
          "lineage": [
            "https://openalex.org/I4210156829"
          ]
        },
        {
          "id": "https://openalex.org/I40347166",
          "display_name": "University of Chicago",
          "ror": "https://ror.org/024mw5h28",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I40347166"
          ]
        },
        {
          "id": "https://openalex.org/I1325899441",
          "display_name": "University Health Network",
          "ror": "https://ror.org/042xt5161",
          "country_code": "CA",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1325899441"
          ]
        }
      ],
      "countries": [
        "CA",
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "Lillian L. Siu",
      "raw_affiliation_strings": [
        "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "From the CHUM, Hospital Notre Dame, Montreal, Quebec; Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; US Oncology, Dallas; Cancer Therapy and Research Center, San Antonio, TX; the University of Chicago, Chicago, IL; and the Pittsburgh Clinical Research Network, Pittsburgh, PA.",
          "institution_ids": [
            "https://openalex.org/I2802654988",
            "https://openalex.org/I4210156829",
            "https://openalex.org/I40347166",
            "https://openalex.org/I1325899441"
          ]
        }
      ]
    }
  ],
  "institution_assertions": [],
  "countries_distinct_count": 2,
  "institutions_distinct_count": 4,
  "corresponding_author_ids": [],
  "corresponding_institution_ids": [],
  "apc_list": null,
  "apc_paid": null,
  "fwci": 22.033,
  "has_fulltext": true,
  "fulltext_origin": "ngrams",
  "cited_by_count": 809,
  "citation_normalized_percentile": {
    "value": 0.957688,
    "is_in_top_1_percent": false,
    "is_in_top_10_percent": true
  },
  "cited_by_percentile_year": {
    "min": 99,
    "max": 100
  },
  "biblio": {
    "volume": "22",
    "issue": "1",
    "first_page": "77",
    "last_page": "85"
  },
  "is_retracted": false,
  "is_paratext": false,
  "primary_topic": {
    "id": "https://openalex.org/T12505",
    "display_name": "Peptidase Inhibition and Analysis",
    "score": 0.9994,
    "subfield": {
      "id": "https://openalex.org/subfields/2730",
      "display_name": "Oncology"
    },
    "field": {
      "id": "https://openalex.org/fields/27",
      "display_name": "Medicine"
    },
    "domain": {
      "id": "https://openalex.org/domains/4",
      "display_name": "Health Sciences"
    }
  },
  "topics": [
    {
      "id": "https://openalex.org/T12505",
      "display_name": "Peptidase Inhibition and Analysis",
      "score": 0.9994,
      "subfield": {
        "id": "https://openalex.org/subfields/2730",
        "display_name": "Oncology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10417",
      "display_name": "Lung Cancer Treatments and Mutations",
      "score": 0.9948,
      "subfield": {
        "id": "https://openalex.org/subfields/2740",
        "display_name": "Pulmonary and Respiratory Medicine"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.9947,
      "subfield": {
        "id": "https://openalex.org/subfields/2730",
        "display_name": "Oncology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    }
  ],
  "keywords": [
    {
      "id": "https://openalex.org/keywords/tolerability",
      "display_name": "Tolerability",
      "score": 0.6523487
    },
    {
      "id": "https://openalex.org/keywords/mucositis",
      "display_name": "Mucositis",
      "score": 0.5287349
    },
    {
      "id": "https://openalex.org/keywords/egfr-inhibitors",
      "display_name": "EGFR Inhibitors",
      "score": 0.47293118
    },
    {
      "id": "https://openalex.org/keywords/erlotinib-hydrochloride",
      "display_name": "Erlotinib Hydrochloride",
      "score": 0.46193802
    }
  ],
  "concepts": [
    {
      "id": "https://openalex.org/C71924100",
      "wikidata": "https://www.wikidata.org/wiki/Q11190",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.9480957
    },
    {
      "id": "https://openalex.org/C2778087573",
      "wikidata": "https://www.wikidata.org/wiki/Q418369",
      "display_name": "Erlotinib",
      "level": 4,
      "score": 0.9266188
    },
    {
      "id": "https://openalex.org/C2778570526",
      "wikidata": "https://www.wikidata.org/wiki/Q653197",
      "display_name": "Rash",
      "level": 2,
      "score": 0.69575626
    },
    {
      "id": "https://openalex.org/C126322002",
      "wikidata": "https://www.wikidata.org/wiki/Q11180",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.667416
    },
    {
      "id": "https://openalex.org/C2778375690",
      "wikidata": "https://www.wikidata.org/wiki/Q7814214",
      "display_name": "Tolerability",
      "level": 3,
      "score": 0.6523487
    },
    {
      "id": "https://openalex.org/C2779438470",
      "wikidata": "https://www.wikidata.org/wiki/Q424401",
      "display_name": "Epidermal growth factor receptor",
      "level": 3,
      "score": 0.52976304
    },
    {
      "id": "https://openalex.org/C2778496288",
      "wikidata": "https://www.wikidata.org/wiki/Q6931269",
      "display_name": "Mucositis",
      "level": 3,
      "score": 0.5287349
    },
    {
      "id": "https://openalex.org/C143998085",
      "wikidata": "https://www.wikidata.org/wiki/Q162555",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.5014374
    },
    {
      "id": "https://openalex.org/C2776530083",
      "wikidata": "https://www.wikidata.org/wiki/Q1783924",
      "display_name": "Head and neck cancer",
      "level": 3,
      "score": 0.47992215
    },
    {
      "id": "https://openalex.org/C2777506169",
      "wikidata": "https://www.wikidata.org/wiki/Q424401",
      "display_name": "EGFR inhibitors",
      "level": 4,
      "score": 0.47293118
    },
    {
      "id": "https://openalex.org/C2908647359",
      "wikidata": "https://www.wikidata.org/wiki/Q2625603",
      "display_name": "Population",
      "level": 2,
      "score": 0.46674186
    },
    {
      "id": "https://openalex.org/C2909325608",
      "wikidata": "https://www.wikidata.org/wiki/Q418369",
      "display_name": "Erlotinib Hydrochloride",
      "level": 5,
      "score": 0.46193802
    },
    {
      "id": "https://openalex.org/C31760486",
      "wikidata": "https://www.wikidata.org/wiki/Q7180990",
      "display_name": "Phases of clinical research",
      "level": 3,
      "score": 0.4158113
    },
    {
      "id": "https://openalex.org/C90924648",
      "wikidata": "https://www.wikidata.org/wiki/Q120569",
      "display_name": "Gastroenterology",
      "level": 1,
      "score": 0.41352528
    },
    {
      "id": "https://openalex.org/C121608353",
      "wikidata": "https://www.wikidata.org/wiki/Q12078",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.3917047
    },
    {
      "id": "https://openalex.org/C197934379",
      "wikidata": "https://www.wikidata.org/wiki/Q2047938",
      "display_name": "Adverse effect",
      "level": 2,
      "score": 0.34097707
    },
    {
      "id": "https://openalex.org/C29730261",
      "wikidata": "https://www.wikidata.org/wiki/Q274160",
      "display_name": "Toxicity",
      "level": 2,
      "score": 0.2962674
    },
    {
      "id": "https://openalex.org/C99454951",
      "wikidata": "https://www.wikidata.org/wiki/Q932068",
      "display_name": "Environmental health",
      "level": 1,
      "score": 0.0
    }
  ],
  "mesh": [
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "Q000037",
      "qualifier_name": "antagonists & inhibitors",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D006258",
      "descriptor_name": "Head and Neck Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D000284",
      "descriptor_name": "Administration, Oral",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000328",
      "descriptor_name": "Adult",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000368",
      "descriptor_name": "Aged",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000369",
      "descriptor_name": "Aged, 80 and over",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D003967",
      "descriptor_name": "Diarrhea",
      "qualifier_ui": "Q000139",
      "qualifier_name": "chemically induced",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D003967",
      "descriptor_name": "Diarrhea",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D018450",
      "descriptor_name": "Disease Progression",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D018572",
      "descriptor_name": "Disease-Free Survival",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000069347",
      "descriptor_name": "Erlotinib Hydrochloride",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005076",
      "descriptor_name": "Exanthema",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005076",
      "descriptor_name": "Exanthema",
      "qualifier_ui": "Q000139",
      "qualifier_name": "chemically induced",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005260",
      "descriptor_name": "Female",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006258",
      "descriptor_name": "Head and Neck Neoplasms",
      "qualifier_ui": "Q000473",
      "qualifier_name": "pathology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006258",
      "descriptor_name": "Head and Neck Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006801",
      "descriptor_name": "Humans",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D008297",
      "descriptor_name": "Male",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D008875",
      "descriptor_name": "Middle Aged",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009362",
      "descriptor_name": "Neoplasm Metastasis",
      "qualifier_ui": "Q000473",
      "qualifier_name": "pathology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009362",
      "descriptor_name": "Neoplasm Metastasis",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009362",
      "descriptor_name": "Neoplasm Metastasis",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009364",
      "descriptor_name": "Neoplasm Recurrence, Local",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009364",
      "descriptor_name": "Neoplasm Recurrence, Local",
      "qualifier_ui": "Q000473",
      "qualifier_name": "pathology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009364",
      "descriptor_name": "Neoplasm Recurrence, Local",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000008",
      "qualifier_name": "administration & dosage",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    }
  ],
  "locations_count": 2,
  "locations": [
    {
      "is_oa": true,
      "landing_page_url": "https://doi.org/10.1200/jco.2004.06.075",
      "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.06.075?role=tab",
      "source": {
        "id": "https://openalex.org/S15137598",
        "display_name": "Journal of Clinical Oncology",
        "issn_l": "0732-183X",
        "issn": [
          "0732-183X",
          "1527-7755"
        ],
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": true,
        "is_core": true,
        "host_organization": "https://openalex.org/P4310315671",
        "host_organization_name": "Lippincott Williams & Wilkins",
        "host_organization_lineage": [
          "https://openalex.org/P4310315671",
          "https://openalex.org/P4310318547"
        ],
        "host_organization_lineage_names": [
          "Lippincott Williams & Wilkins",
          "Wolters Kluwer"
        ],
        "type": "journal"
      },
      "license": null,
      "license_id": null,
      "version": "publishedVersion",
      "is_accepted": true,
      "is_published": true
    },
    {
      "is_oa": false,
      "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/14701768",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S4306525036",
        "display_name": "PubMed",
        "issn_l": null,
        "issn": null,
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": false,
        "is_core": false,
        "host_organization": "https://openalex.org/I1299303238",
        "host_organization_name": "National Institutes of Health",
        "host_organization_lineage": [
          "https://openalex.org/I1299303238"
        ],
        "host_organization_lineage_names": [
          "National Institutes of Health"
        ],
        "type": "repository"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    }
  ],
  "best_oa_location": {
    "is_oa": true,
    "landing_page_url": "https://doi.org/10.1200/jco.2004.06.075",
    "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.06.075?role=tab",
    "source": {
      "id": "https://openalex.org/S15137598",
      "display_name": "Journal of Clinical Oncology",
      "issn_l": "0732-183X",
      "issn": [
        "0732-183X",
        "1527-7755"
      ],
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": true,
      "is_core": true,
      "host_organization": "https://openalex.org/P4310315671",
      "host_organization_name": "Lippincott Williams & Wilkins",
      "host_organization_lineage": [
        "https://openalex.org/P4310315671",
        "https://openalex.org/P4310318547"
      ],
      "host_organization_lineage_names": [
        "Lippincott Williams & Wilkins",
        "Wolters Kluwer"
      ],
      "type": "journal"
    },
    "license": null,
    "license_id": null,
    "version": "publishedVersion",
    "is_accepted": true,
    "is_published": true
  },
  "sustainable_development_goals": [
    {
      "display_name": "Good health and well-being",
      "score": 0.85,
      "id": "https://metadata.un.org/sdg/3"
    }
  ],
  "grants": [],
  "datasets": [],
  "versions": [],
  "referenced_works_count": 25,
  "referenced_works": [
    "https://openalex.org/W1581824974",
    "https://openalex.org/W1596261235",
    "https://openalex.org/W1898337686",
    "https://openalex.org/W2005204942",
    "https://openalex.org/W2021260623",
    "https://openalex.org/W2032359283",
    "https://openalex.org/W2057458801",
    "https://openalex.org/W2062057316",
    "https://openalex.org/W2097584581",
    "https://openalex.org/W2109823193",
    "https://openalex.org/W2135836172",
    "https://openalex.org/W2155066333",
    "https://openalex.org/W2156203734",
    "https://openalex.org/W2164686711",
    "https://openalex.org/W2169748783",
    "https://openalex.org/W2171128277",
    "https://openalex.org/W2196200542",
    "https://openalex.org/W2206786835",
    "https://openalex.org/W2285438928",
    "https://openalex.org/W2400222249",
    "https://openalex.org/W2412846321",
    "https://openalex.org/W2419263944",
    "https://openalex.org/W2421767414",
    "https://openalex.org/W2911681256",
    "https://openalex.org/W4247915047"
  ],
  "related_works": [
    "https://openalex.org/W562420810",
    "https://openalex.org/W4381887247",
    "https://openalex.org/W4249306487",
    "https://openalex.org/W2801862162",
    "https://openalex.org/W2551486460",
    "https://openalex.org/W2150724094",
    "https://openalex.org/W2120992361",
    "https://openalex.org/W2110701817",
    "https://openalex.org/W2103245557",
    "https://openalex.org/W1483707553"
  ],
  "abstract_inverted_index": {
    "To": [
      0
    ],
    "determine": [
      1
    ],
    "the": [
      2,
      20,
      77,
      140,
      192,
      206
    ],
    "efficacy": [
      3
    ],
    "and": [
      4,
      22,
      84,
      139,
      189,
      200,
      224
    ],
    "safety": [
      5
    ],
    "profiles": [
      6
    ],
    "of": [
      7,
      19,
      32,
      44,
      57,
      68,
      104,
      123,
      202,
      232
    ],
    "erlotinib": [
      8,
      39,
      71
    ],
    "in": [
      9,
      115,
      159,
      198,
      212,
      218,
      235
    ],
    "patients": [
      10,
      60,
      69,
      92,
      117,
      163
    ],
    "with": [
      11,
      25,
      38
    ],
    "advanced": [
      12
    ],
    "recurrent": [
      13,
      27
    ],
    "and/or": [
      14,
      28,
      89
    ],
    "metastatic": [
      15,
      29
    ],
    "squamous": [
      16
    ],
    "cell": [
      17
    ],
    "cancer": [
      18
    ],
    "head": [
      21
    ],
    "neck": [
      23
    ],
    "(HNSCC).Patients": [
      24
    ],
    "locally": [
      26
    ],
    "HNSCC,": [
      30
    ],
    "regardless": [
      31
    ],
    "their": [
      33
    ],
    "HER1/EGFR": [
      34,
      186
    ],
    "status,": [
      35
    ],
    "were": [
      36,
      52,
      61,
      191
    ],
    "treated": [
      37
    ],
    "at": [
      40,
      72,
      166
    ],
    "an": [
      41,
      99
    ],
    "initial": [
      42
    ],
    "dose": [
      43,
      82,
      87
    ],
    "150": [
      45,
      73
    ],
    "mg": [
      46,
      74
    ],
    "daily.": [
      47
    ],
    "Dose": [
      48
    ],
    "reductions": [
      49,
      88
    ],
    "or": [
      50
    ],
    "escalations": [
      51
    ],
    "allowed": [
      53
    ],
    "based": [
      54,
      184
    ],
    "on": [
      55,
      96,
      185
    ],
    "tolerability": [
      56
    ],
    "erlotinib.One-hundred": [
      58
    ],
    "fifteen": [
      59
    ],
    "enrolled": [
      62
    ],
    "onto": [
      63
    ],
    "this": [
      64,
      219,
      236
    ],
    "study.": [
      65
    ],
    "Forty-seven": [
      66
    ],
    "percent": [
      67
    ],
    "received": [
      70
    ],
    "daily": [
      75
    ],
    "throughout": [
      76
    ],
    "entire": [
      78
    ],
    "study,": [
      79,
      97
    ],
    "6%": [
      80
    ],
    "had": [
      81
    ],
    "escalations,": [
      83
    ],
    "46%": [
      85
    ],
    "required": [
      86
    ],
    "interruptions.": [
      90
    ],
    "Five": [
      91
    ],
    "achieved": [
      93
    ],
    "partial": [
      94
    ],
    "responses": [
      95
    ],
    "for": [
      98,
      119
    ],
    "overall": [
      100,
      142,
      160
    ],
    "objective": [
      101
    ],
    "response": [
      102
    ],
    "rate": [
      103
    ],
    "4.3%": [
      105
    ],
    "(95%": [
      106,
      133,
      147
    ],
    "CI,": [
      107,
      134,
      148
    ],
    "1.4%": [
      108
    ],
    "to": [
      109,
      136,
      150,
      210
    ],
    "9.9%).": [
      110
    ],
    "Disease": [
      111
    ],
    "stabilization": [
      112
    ],
    "was": [
      113,
      130,
      144,
      182,
      208,
      215
    ],
    "maintained": [
      114
    ],
    "44": [
      116
    ],
    "(38.3%)": [
      118
    ],
    "a": [
      120,
      156
    ],
    "median": [
      121,
      127,
      141
    ],
    "duration": [
      122
    ],
    "16.1": [
      124
    ],
    "weeks.": [
      125
    ],
    "The": [
      126
    ],
    "progression-free": [
      128
    ],
    "survival": [
      129,
      143,
      161
    ],
    "9.6": [
      131
    ],
    "weeks": [
      132
    ],
    "8.1": [
      135
    ],
    "12.1": [
      137
    ],
    "weeks),": [
      138
    ],
    "6.0": [
      145
    ],
    "months": [
      146
    ],
    "4.8": [
      149
    ],
    "7.0": [
      151
    ],
    "months).": [
      152
    ],
    "Subgroup": [
      153
    ],
    "analyses": [
      154
    ],
    "revealed": [
      155
    ],
    "significant": [
      157
    ],
    "difference": [
      158,
      181
    ],
    "favoring": [
      162
    ],
    "who": [
      164,
      174
    ],
    "developed": [
      165
    ],
    "least": [
      167
    ],
    "grade": [
      168
    ],
    "2": [
      169
    ],
    "skin": [
      170
    ],
    "rashes": [
      171
    ],
    "versus": [
      172
    ],
    "those": [
      173
    ],
    "did": [
      175
    ],
    "not": [
      176
    ],
    "(P": [
      177
    ],
    "=.045),": [
      178
    ],
    "whereas": [
      179
    ],
    "no": [
      180
    ],
    "detected": [
      183
    ],
    "expression.": [
      187
    ],
    "Rash": [
      188
    ],
    "diarrhea": [
      190
    ],
    "most": [
      193,
      213
    ],
    "common": [
      194
    ],
    "drug-related": [
      195
    ],
    "toxicities,": [
      196
    ],
    "encountered": [
      197
    ],
    "79%": [
      199
    ],
    "37%": [
      201
    ],
    "patients,": [
      203
    ],
    "respectively,": [
      204
    ],
    "though": [
      205
    ],
    "severity": [
      207
    ],
    "mild": [
      209
    ],
    "moderate": [
      211
    ],
    "cases.Erlotinib": [
      214
    ],
    "well": [
      216
    ],
    "tolerated": [
      217
    ],
    "heavily": [
      220
    ],
    "pretreated": [
      221
    ],
    "HNSCC": [
      222
    ],
    "population": [
      223
    ],
    "produced": [
      225
    ],
    "prolonged": [
      226
    ],
    "disease": [
      227
    ],
    "stabilization;": [
      228
    ],
    "hence,": [
      229
    ],
    "further": [
      230
    ],
    "evaluation": [
      231
    ],
    "its": [
      233
    ],
    "role": [
      234
    ],
    "tumor": [
      237
    ],
    "type": [
      238
    ],
    "is": [
      239
    ],
    "warranted.": [
      240
    ]
  },
  "abstract_inverted_index_v3": null,
  "cited_by_api_url": "https://api.openalex.org/works?filter=cites:W2103134643",
  "counts_by_year": [
    {
      "year": 2025,
      "cited_by_count": 3
    },
    {
      "year": 2024,
      "cited_by_count": 14
    },
    {
      "year": 2023,
      "cited_by_count": 14
    },
    {
      "year": 2022,
      "cited_by_count": 18
    },
    {
      "year": 2021,
      "cited_by_count": 22
    },
    {
      "year": 2020,
      "cited_by_count": 17
    },
    {
      "year": 2019,
      "cited_by_count": 21
    },
    {
      "year": 2018,
      "cited_by_count": 21
    },
    {
      "year": 2017,
      "cited_by_count": 30
    },
    {
      "year": 2016,
      "cited_by_count": 30
    },
    {
      "year": 2015,
      "cited_by_count": 35
    },
    {
      "year": 2014,
      "cited_by_count": 33
    },
    {
      "year": 2013,
      "cited_by_count": 46
    },
    {
      "year": 2012,
      "cited_by_count": 70
    }
  ],
  "updated_date": "2025-05-31T21:39:27.551772",
  "created_date": "2016-06-24"
}